NCT01795573View on ClinicalTrials.gov

Ex-vivo Expanded Donor Regulatory T Cells for Prevention of Acute Graft-Versus-Host Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

October 29, 2014

Primary Completion Date

August 14, 2020

Study Completion Date

August 14, 2020

Conditions
Graft Versus Host Disease
Interventions
BIOLOGICAL

Cultured Treg cells

Co-culturing of recipient dendritic cells and donor Treg. Treg administration will occur 2 days before the allogeneic stem cell transplant (i.e. day -2 with reference of day 0 as stem cell infusion date).

Trial Locations (1)

33612

H Lee Moffitt Cancer Center, Tampa

All Listed Sponsors
lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER

NCT01795573 - Ex-vivo Expanded Donor Regulatory T Cells for Prevention of Acute Graft-Versus-Host Disease | Biotech Hunter | Biotech Hunter